Invo Fertility Q1 FY26 net loss widens to $5.5 million; revenue rises 23% to $2 million
PUBT · 3d ago
Share
Listen to the news
- Invo Fertility posted Q1 2026 revenue of $2.02 million, up 23% year over year.
- Net loss from continuing operations widened to $5.5 million, including a $3.8 million non-cash loss tied to warrant fair-value changes.
- Cash climbed to $4.9 million at March 31, 2026, up from $2.1 million at year-end 2025.
- All Series C-2 Preferred Stock was converted or retired, eliminating warrant liabilities; stockholders’ equity more than doubled to $15 million.
- The clinic platform expanded with the February acquisition of Family Beginnings, adding a fourth U.S. fertility clinic.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606220900PRIMZONEFULLFEED9750239) on June 22, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved